Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia

NCT01709032 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Thalassemia Major With Severe Transfusional Iron Overload

Interventions

DRUG: Deferasirox and deferiprone

Sponsor

Children's Hospital of Philadelphia

Collaborators

[object Object]
[object Object]